DLG
PTX

Daniel L. Goodwin’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Daniel L. Goodwin’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,268
Closed -$14K – 107
2016
Q3 		$14K Hold
2,268
– – 0.01% 108
2016
Q2 		$10K Hold
2,268
– – ﹤0.01% 112
2016
Q1 		$24K Hold
2,268
– – 0.01% 108
2015
Q4 		$67K Hold
2,268
– – 0.02% 106
2015
Q3 		$72K Hold
2,268
– – 0.02% 105
2015
Q2 		$134K Buy
+2,268
New +$160K 0.04% 100

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Daniel L. Goodwin's PTX Position: Q4 2016 in Review

Daniel L. Goodwin sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2016, closing a stake of 2,268 shares — an estimated $14K sold.

Daniel L. Goodwin first reported a position in PTX in Q2 2015 and held it in 6 quarters. The position peaked at $134K in Q2 2015. 34 funds tracked by Wall St. Rank hold PTX as of Q4 2016.

  • Daniel L. Goodwin reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
  • Daniel L. Goodwin sold 2,268 Pernix Therapeutics Holdings, Inc. shares in Q4 2016, an estimated $14K.
  • Daniel L. Goodwin first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2015 and held it in 6 quarters.
  • Daniel L. Goodwin's Pernix Therapeutics Holdings, Inc. position peaked at $134K in Q2 2015.
  • 34 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2016.

Based on Daniel L. Goodwin's 13F filing for Q4 2016, filed 19 Jan 2017.